Board of directors

Dr Merilyn J Sleigh

BSc, PhD, DipCorp Man, FTSE

Dr Sleigh was formerly CEO & Managing Director of EvoGenix limited, Dean, faculty of Life Sciences, University of NSW, Director, Research & Development at Peptech Ltd and Scientist & Senior Manager, CSIRO. She is currently a director of a private biotechnology company and advises government and life sciences companies and their investors.

A Non-executive Director of Clover Corporation Limited since 9 July 2008. She is a member of the audit and the remuneration committees.

Listed company directorships held during the last three include:

  • EvoGenix Limited, appointed October 2001, resigned August 2007.

News & Media

  • Wednesday, 21 March 2012
    Clover sales increase by 27.8% in the first half of FY2012...read on >>
  • Thursday, 12 January 2012
    Under the radar Report highlights Clover Corporation...read on >>
  • Tuesday, 22 November 2011
    Clover Corporation sales increase by 24% in the first quarter of FP2012...read on >>
  • Monday, 31 October 2011
    Microequities includes profile of Clover Corporation in microcapBOOKâ„¢ ...read on >>
  • Wednesday, 21 September 2011
    Clover announces record net profit of $4,603 million...read on >>
  • Friday, 02 September 2011
    Clover terminates distribution agreement with CPI...read on >>
  • Monday, 15 August 2011
    Clover announces 3-year research program with CSIRO...read on >>